Lupin Limited has launched the generic version of Antara (Fenofibrate) Capsules, 30 mg and 90 mg, of its fully-owned Lupin Atlantis Holdings in the US.

According to the Indian pharma company, Fenofibrate Capsules are approved to be used as an adjunctive therapy to diet to decrease elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (total-c), Triglycerides (TG) and apolopoprotein B (Apo B), and to raise the levels of high-density lipoprotein cholesterol (HDL-C) in adults suffering from primary hypercholesterolemia.

According to IQVIA MAT September 2021, Fenofibrate Capsules had estimated annual sales of $7 million in the US.

  Antara, Cholesterol, Fenofibrate Capsules, Lupin, Lupin Atlantis Holdings, USA